Advertisement

Imaging Findings in Liver Malignancies

  • Christos N. Mourmouris
Chapter

Abstract

The liver is an important organ in the era of oncology. Primary hepatic neoplasms have significantly increased during the last decades. The liver also is the most common site of metastasis from primary tumors such as in the colon, breast, lung, pancreas, and stomach. In both cases, the accurate detection of malignant liver disease is crucial to patient management. However, since benign liver lesions are also very common, it is important to use all the available imaging modalities for the characterization of a focal liver lesion. The goal of liver imaging in oncology is detection and characterization of a lesion, staging of a neoplasm, evaluation of treatment response, and assessment of vascular anatomy for surgical planning or chemotherapy.

References

  1. 1.
    Bolondi J (2003) Screening for hepatocellular carcinoma in cirrhosis. J Hepatol 39:1076–1084CrossRefGoogle Scholar
  2. 2.
    Vilana R, Forner A, Bianchi L et al (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhotic patients may display a vascular pattern similar to hepatocellular on contrast enhanced ultrasound. Hepatology 51:2020–2029CrossRefGoogle Scholar
  3. 3.
    Iannaccone R, Laghi A, Catalano C et al (2005) Hepatocellular carcinoma: role of unenhanced and delayed phase multi-detector row helical CT in patients with cirrhosis. Radiology 234:460–467CrossRefGoogle Scholar
  4. 4.
    Choi B, Lee J (2010) Advancement in HCC imaging: diagnosis, staging and treatment efficacy assessments. J Hepatobiliary Pancreat Sci 17:369–373CrossRefGoogle Scholar
  5. 5.
    Colli A, Fraquelli M, Casazza G et al (2006) Accuracy of ultrasonography, spiral CT, magnetic resonance and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 101:513–523CrossRefGoogle Scholar
  6. 6.
    Kim SH, Choi BI, Lee JY et al (2008) Diagnostic accuracy of MDCT and contrast-enhanced MRI in the detection of hepatocellular carcinomas meeting the Milan criteria before liver transplantation. Intervirology 51(suppl 1):52–60CrossRefGoogle Scholar
  7. 7.
    Ariff B, Lloyd C, Khan S et al (2009) Imaging of liver cancer. World J Gastroenterol 15(11):1289–1300CrossRefGoogle Scholar
  8. 8.
    Brancatelli G, Federle MP, Grazioli L et al (2002) Hepatocellular carcinoma in non-cirrhotic liver: CT clinical and pathological findings in 39 US residents. Radiology 222:89–94CrossRefGoogle Scholar
  9. 9.
    Marrero JA, Hussain HK, Nghiem HV et al (2005) Improving the prediction of hepatocellular carcinoma in cirrhotic patients with arterial enhancing liver mass. Liver Transpl 11:281–289CrossRefGoogle Scholar
  10. 10.
    Willatt JM, Hussain HK, Adusumilli S et al (2008) MR imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 247:311–330CrossRefGoogle Scholar
  11. 11.
    Kim SH, Kim CS, Chung GH et al (2009) Gadoxetic- acid enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR 192:1675–1681CrossRefGoogle Scholar
  12. 12.
    Ahn S, Kim M, Lim J et al (2010) Added value of gadoxetic acid—enhanced hepatobiliary phase MR imaging in the diagnosis of hepatocellular carcinoma. Radiology 255:459466CrossRefGoogle Scholar
  13. 13.
    Vandecaveye V, De Keyzer F, Verslype C et al (2009) DWI provides additional value to conventional dynamic contrast enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol 19:2456–2466CrossRefGoogle Scholar
  14. 14.
    Santillan C, Tang A (2014) Understanding LI RADS: a primer for practical use. Magn Reson Imaging Clin N Am 22:337–352CrossRefGoogle Scholar
  15. 15.
    Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. Practice guidelines committee, American association for the study of liver diseases. Hepatology 42:1208–1236CrossRefGoogle Scholar
  16. 16.
    Bruix J, Sherman M, Llovet JM et al (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona 2000 EASL conference. European association for the study of the liver. J Hepatol 35:421–430CrossRefGoogle Scholar
  17. 17.
    Forner A, Ayuso C, Varela M et al (2009) Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma. Cancer 115:616–623CrossRefGoogle Scholar
  18. 18.
    Sainani N, Catalano O, Holalkere N et al (2008) Cholangiocarcinoma: current and novel imaging techniques. Radiographics 28:1263–1287CrossRefGoogle Scholar
  19. 19.
    Slattery J, Sahani D (2006) What is the current state of the art imaging for detection and staging of cholangiocarcinoma. Oncologist 11:913–922CrossRefGoogle Scholar
  20. 20.
    Baron R, Ferris J (2004) Primary tumors of the liver and the biliary tract. In: Husband J, Reznek R (eds) Imaging in oncology. Taylor and Francis, London, pp 245–272Google Scholar
  21. 21.
    Ayuso C, Rimola J, Garcia-Criado A (2011) Imaging of HCC. Abdom Imaging 37:215–230CrossRefGoogle Scholar
  22. 22.
    Rosch T, Meining A, Fruhmorgen S et al (2002) A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT and EUS in biliary strictures. Gatsrointest Endosc 55:870–876CrossRefGoogle Scholar
  23. 23.
    Paulson EK (2001) Evaluation of the liver metastatic disease. Semin Liver Dis 21:225–236CrossRefGoogle Scholar
  24. 24.
    Konopke R, Kersting S, Saeger HD et al (2005) Detection of liver lesions by contrast enhanced ultrasound—comparison to intraoperative findings. Ultraschall Med 26:107–113CrossRefGoogle Scholar
  25. 25.
    Ward J, Naik KS, Guthrie JA et al (1999) Hepatic lesion detection: comparison of MR imaging after the administration of superparamagnetic iron oxide with dual-phase CT using alternative free response receiver operating characteristic analysis. Radiology 210:459–466CrossRefGoogle Scholar
  26. 26.
    Oliva M, Saini S (2004) Liver cancer imaging: role of CT, MRI, US and PET. Cancer Imaging 4:S42–S46.  https://doi.org/10.1102/1470-7330.2004.0011 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Niekel M, Bipat S, Stoker J et al (2010) Diagnostic Imaging of colorectal liver metastases with CT, MR imaging FDG PET and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257:674–684CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Christos N. Mourmouris
    • 1
  1. 1.Imaging Department Hygeia HospitalMarousiGreece

Personalised recommendations